Sanofi : La FDA va examiner la demande d’approbation de l’isatuximab dans le traitement potentiel du myélome multiple réfractaire ou en rechute   

Frank Burrell
Scientific Storytelling

Suma Ramadas, PhD
Medical Affairs

Pat Purcell
Meeting Engagement

Brenda Snow
Authentic Patient Voice

Daniel Sontupe
Market Access

Liz Kane
Impactful Strategy

Stacey Gandler
Brand Nourishment

Joey Cohen
Medication Adherence

Matthew Durham
Omnidynamic Marketing

Matt Turner
Patient Affordability

Paul Theisen
Patient Acquisition

Bud Bilanich
Success Coach

David Linetsky
Point-of-Care Marketing

Amy Giles
Increasing Engagement